You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myelodysplasia Syndrome

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • (no location specified)
Nov 29, 2021

Natural History Study of GATA2 Deficiency and Related Disorders

Recruiting
  • GATA2 Deficiency
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Collecting and Storing Blood, Bone Marrow, and Other Samples

    Active, not recruiting
    • Acute Leukemia
    • +2 more
    • biologic sample preservation procedure
    • Mountain View, California
    • +141 more
    Aug 2, 2022

    Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • +2 more
    • Fludarabine and Busulfan
    • Fludarabine and Melphalan
    • Wuhan, Hubei, China
      Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
    Jan 5, 2023

    Myelodysplastic Syndrome Trial in France, Germany, Spain (Lenalidomide, Placebo)

    Active, not recruiting
    • Myelodysplastic Syndrome
    • Strasbourg, Bajo Rin, France
    • +24 more
    Nov 22, 2021

    Acute Myeloid Leukemia, MDS Trial (IMM01, Azacitidine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • (no location specified)
    Nov 21, 2021

    Anemia, MDS Trial in Germany (Canakinumab Injection)

    Recruiting
    • Anemia
    • Myelodysplastic Syndromes
    • Canakinumab Injection
    • Berlin, Germany
    • +5 more
    Nov 8, 2022

    Neural Tube Defects, Anemia, Leukemia, Myeloid Trial in Stanford (CIK cells, Cyclosporine, Mycophenolate Mofetil)

    Completed
    Has Results
    • Neural Tube Defects
    • +5 more
    • CIK cells
    • +4 more
    • Stanford, California
      Stanford University School of Medicine
    Apr 18, 2019

    Myelodysplasia, Leukemia Trial in Providence (chemo)

    Terminated
    Has Results
    • Myelodysplasia
    • Leukemia
    • Providence, Rhode Island
      Lifespan Hospitals
    Jan 5, 2022

    Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)

    Recruiting
    • Severe Aplastic Anemia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    GATA2, Immunodeficiency, MDS Trial run by the National Cancer Institute (NCI) (procedure, drug, biological)

    Recruiting
    • GATA2
    • +2 more
    • Allogeneic HSCT
    • +8 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 18, 2022

    Healthy Volunteers of Fanconi Anemia, Myeloproliferative

    Completed
    • Chronic Myeloproliferative Disorders
    • +3 more
    • microarray analysis
    • +8 more
    • Portland, Oregon
      Knight Cancer Institute at Oregon Health and Science University
    Jun 30, 2022

    Biology of Long-Term Late Effects Following Hematopoietic Cell

    Active, not recruiting
    • Acute Lymphoblastic Leukemia/Lymphoma
    • +4 more
      • Scottsdale, Arizona
      • +31 more
      Mar 8, 2022

      Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine, Total Marrow

      Terminated
      • Acute Myeloid Leukemia
      • +3 more
      • Indianapolis, Indiana
        Indiana University Melvin & Bren Simon Cancer Center
      Feb 22, 2022

      Acute Myeloid Leukemia, Myelodysplasia Trial in United Kingdom (Oral azacitidine, Matched )

      Recruiting
      • Acute Myeloid Leukemia
      • Myelodysplasia
      • Oral azacitidine
      • Matched placebo
      • Birmingham, United Kingdom
      • +20 more
      Oct 14, 2021

      Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Azacitidine, Sargramostim)

      Completed
      Has Results
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome
      • Baltimore, Maryland
        The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Sep 23, 2022

      Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Basiliximab, Carmustine, Cytarabine)

      Recruiting
      • Recurrent Hodgkin Lymphoma
      • Refractory Hodgkin Lymphoma
      • Basiliximab
      • +6 more
      • Duarte, California
        City of Hope Medical Center
      Jun 16, 2022

      Leukemia, MDS Trial in United States (biological, drug, procedure, radiation)

      Completed
      • Leukemia
      • Myelodysplastic Syndromes
      • anti-thymocyte globulin
      • +7 more
      • Los Angeles, California
      • +5 more
      Jul 1, 2019

      Acute Leukemia, Myelodysplasia, Chronic Graft-versus-host-disease Trial in Australia, Canada (Cyclophosphamide, Anti-Thymocyte

      Recruiting
      • Acute Leukemia
      • +2 more
      • Darlinghurst, New South Wales, Australia
      • +8 more
      Aug 30, 2021

      GENOMED4ALL: Improving MDS Classification and Prognosis by AI

      Active, not recruiting
      • Myelodysplastic Syndromes
        • Milano, Italy
          Istituto Clinico Humanitas
        Jun 28, 2021

        Acute Myeloid Leukemia, Myelodysplasia Trial in United States (MGTA-117)

        Recruiting
        • Acute Myeloid Leukemia
        • Myelodysplasia
        • MGTA-117
        • Duarte, California
        • +7 more
        Nov 23, 2022

        Myelodysplasia, Hematologic Malignancy Trial in Columbus (CliniMACS® TCRaß/CD19 Combined Depletion System)

        Recruiting
        • Myelodysplasia
        • Hematologic Malignancy
        • CliniMACS® TCRαβ/CD19 Combined Depletion System
        • Columbus, Ohio
          Nationwide Children's Hospital
        Jan 11, 2022

        Nephrotic Syndrome in Children Trial in China (Adrenocorticotrophic Hormone, Steroid)

        Recruiting
        • Nephrotic Syndrome in Children
        • Wuhan, Hubei, China
        • +7 more
        Oct 8, 2023

        Participants With Sanfilippo Syndrome Type IIIC

        Not yet recruiting
        • Sanfilippo Syndrome Type C
          • Bron, France
            Hospices Civils De Lyon
          Apr 20, 2023

          Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid

          Completed
          • Minimal Residual Disease
          • +3 more
          • Daratumumab
          • +2 more
          • Columbus, Ohio
            Ohio State University Comprehensive Cancer Center
          Mar 2, 2022